Sector
Cambridge Innovation leads £4m round for Inviata
Deal is first for Cambridge Innovation in life sciences sector
Molecular Partners launches Swiss IPO
Venture-capital backed biotech plans to raise CHF 125m for R&D
Ballast Nedam completes asset sale with Bencis, calls off H2 deal
Bencis has created European Clean Fuel Company from Ballast assets
Bridgepoint's Fat Face completes £210m refinancing
Refinancing believed to include ТЃ65m dividend recap
Deal in focus: Enterprise makes 12x money on AVG exit
AVG's market cap increased under Enterprise's ownership by 11.5x
EQT's XXL valued at NOK 8.65bn ahead of IPO
Swedish GP will be subject to six-month lock-up period.
LBO Partners' AMS bolts on Asdia
Capzanine arranged a unitranche facility for the bolt-on
Rocket's Netzoptiker files for insolvency
Omnes Capital loses out on March 2010 investment
Inveready leads €600,000 round for Conzoom
Deal is first completed through Inveready's latest fund
Active Venture Partners backs Odilo
Fresh capital to support company's expansion in US and Latin America
Maj Invest takes majority stake in ProLøn
Former majority shareholder Gert Davidsen will retain a stake
Bayern Kapital et al. exit commercetools
HTGF, BayBG and Bayern Kapital invested less than €10m in 2011
HC Royalty injects €45m into Cardiorentis
Swiss company focuses on treatments for acute heart failure
Sovereign buys SJD and Nixon
Deal values combined businesses at ТЃ100m
Emertec et al. commit further €2.4m to Lineazen
Agriculture-focused Capagro launched in April 2014
HTGF invests in opentabs
Munich-based food ordering app will invest in its developer team
VC-backed Affimed raises $56m in IPO
Backers include Aeris, BioMedInvest and Life Sciences Partners
New Russian VC Restart Capital launches
St Petersburg-based venture fund targets struggling internet companies
SmartCap et al. exit GrabCAD for reported $100m
Sale likely to be largest Estionian exit since Skype in 2011
Aglaia launches Oncology Fund II
Fund focuses exclusively on biotechs developing anti-cancer therapies
VC-backed ProQR raises $97.5m in IPO
Listed Dutch biotech develops drugs designed for the treatment of genetic disorders
Hellman & Friedman's Scout24 mulls IPO
Announcement comes on same day as Zalando confirms October IPO
Zalando confirms €21.50 share price for IPO
Overallotment option has been exercised to reap proceeds of €605m
Tengelmann and IBB back 42reports
Seven-figure sum invested for developing next generation of products